Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person Takeda, Makoto

Class:IdPerson:9684965
_displayNameTakeda, Makoto
_timestamp2020-04-22 10:11:43
created[InstanceEdit:9684954] Jassal, Bijay, 2020-04-22
firstnameMakoto
initialM
surnameTakeda
(author)[LiteratureReference:9684962] Identification of Nafamostat as a Potent Inhibitor of Middle East Respiratory Syndrome Coronavirus S Protein-Mediated Membrane Fusion Using the Split-Protein-Based Cell-Cell Fusion Assay
[LiteratureReference:9687564] Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2
[LiteratureReference:9705131] Functionally distinct effects of the C-terminal regions of IKKε and TBK1 on type I IFN production
[LiteratureReference:9770280] Proteolytic activation of SARS-CoV-2 spike protein
[Change default viewing format]
No pathways have been reviewed or authored by Takeda, Makoto (9684965)